CY915A - Pyrrolo (3,4-b) pyrazine derivatives - Google Patents
Pyrrolo (3,4-b) pyrazine derivativesInfo
- Publication number
- CY915A CY915A CY915A CY91573A CY915A CY 915 A CY915 A CY 915A CY 915 A CY915 A CY 915A CY 91573 A CY91573 A CY 91573A CY 915 A CY915 A CY 915A
- Authority
- CY
- Cyprus
- Prior art keywords
- pyrrolo
- pyrazine derivatives
- pyrazine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7200505A FR2166314A1 (en) | 1972-01-07 | 1972-01-07 | 6-substd 5-(4-methyl 1-piperazinyl)carbonyloxy 7-oxo - 5,6-dihydro-pyrrolo (3,4-b)pyrazines - tranquillizers and anticonvuls |
FR7239731A FR2205318A2 (en) | 1972-11-09 | 1972-11-09 | 6-substd 5-(4-methyl 1-piperazinyl)carbonyloxy 7-oxo - 5,6-dihydro-pyrrolo (3,4-b)pyrazines - tranquillizers and anticonvuls |
Publications (1)
Publication Number | Publication Date |
---|---|
CY915A true CY915A (en) | 1977-12-23 |
Family
ID=26216824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY915A CY915A (en) | 1972-01-07 | 1973-01-05 | Pyrrolo (3,4-b) pyrazine derivatives |
Country Status (22)
Country | Link |
---|---|
US (1) | US3862149A (sl) |
JP (3) | JPS523952B2 (sl) |
AR (1) | AR195097A1 (sl) |
AT (1) | AT323181B (sl) |
AU (1) | AU466586B2 (sl) |
BE (1) | BE793730A (sl) |
CA (1) | CA991183A (sl) |
CY (1) | CY915A (sl) |
DD (1) | DD102698A5 (sl) |
DE (1) | DE2300491C3 (sl) |
DK (1) | DK139359B (sl) |
FI (1) | FI54124C (sl) |
GB (1) | GB1358680A (sl) |
HK (1) | HK60077A (sl) |
HU (1) | HU164821B (sl) |
IE (1) | IE37056B1 (sl) |
IL (1) | IL41232A (sl) |
LU (1) | LU66800A1 (sl) |
NL (1) | NL7217852A (sl) |
NO (1) | NO136843C (sl) |
OA (1) | OA04285A (sl) |
SE (1) | SE398503B (sl) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR208414A1 (es) * | 1974-11-07 | 1976-12-27 | Rhone Poulenc Ind | Procedimiento para obtener nuevos derivados de la((acil-4piperazinil-1)carboniloxi-5 pirrolinona-2) |
FR2322601A1 (fr) * | 1975-09-04 | 1977-04-01 | Rhone Poulenc Ind | Nouveaux derives de l'isoindoline, leur preparation et les compositions qui les contiennent |
JPS5680585A (en) * | 1979-11-30 | 1981-07-01 | Toyoda Gosei Kk | High pressure hose |
JPS57144860A (en) * | 1981-03-04 | 1982-09-07 | Matsushita Electric Ind Co Ltd | Secondary side water pressure controller for water cooler |
DE3378763D1 (en) * | 1982-04-02 | 1989-02-02 | Takeda Chemical Industries Ltd | Condensed pyrrolinone derivatives, and their production |
JPS6169773A (ja) * | 1984-09-14 | 1986-04-10 | Takeda Chem Ind Ltd | イソインドリノン誘導体 |
JPS6297400U (sl) * | 1985-12-09 | 1987-06-20 | ||
FR2607504B1 (fr) * | 1986-12-02 | 1989-01-27 | Rhone Poulenc Sante | Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent |
FR2671800B1 (fr) * | 1991-01-17 | 1993-03-12 | Rhone Poulenc Rorer Sa | Derive de la 5h-pyrrolo[3,4-b]pyrazine optiquement actif, sa preparation et les compositions pharmaceutiques qui le contiennent. |
WO1993010787A1 (en) * | 1991-12-02 | 1993-06-10 | Sepracor, Inc. | Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (+) zopiclone |
WO1993010788A1 (en) * | 1991-12-02 | 1993-06-10 | Sepracor, Inc. | Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (-) zopiclone |
US5786357A (en) * | 1991-12-02 | 1998-07-28 | Sepracor Inc. | Methods and compositions for treating sleep disorders, convulsive seizures and other disorders using optically pure (+) zopiclone |
ATE247967T1 (de) | 1998-06-09 | 2003-09-15 | Takeda Chemical Industries Ltd | Pharmazeutische kombination mit einem trizyclischen komponent und mindestens einem aus zolpidem, zopiclone und brotizolam, zur behandlung von schlafstörungen |
US6339086B1 (en) | 1999-05-14 | 2002-01-15 | Swpracor, Inc. | Methods of making and using N-desmethylzopiclone |
ES2203319B1 (es) * | 2002-04-03 | 2005-03-01 | Universidad De Oviedo | Nuevos carbonatos opticamente activos como intermedios en la sintesis de (+)-zopiclona. |
DK1691811T3 (da) | 2003-12-11 | 2014-10-20 | Sunovion Pharmaceuticals Inc | Kombination af et sedativ og en neurotransmittermodulator og fremgangsmåder til forbedring af søvnkvaliteten og behandling af depression |
MX2008000250A (es) | 2005-07-06 | 2008-03-19 | Sepracor Inc | Combinaciones de eszopiclona y trans-4-(3,4-diclorofenil)-1,2,3,4- tetrahidro-n-metil-1-naftalenamina o trans 4-(3,4-diclorofenil)-1, 2,3,4-tetrahidro-1-naftalenamina y metodos de tratamiento de menopausia y trastornos del estado de animo, ansiedad y |
JP2009500420A (ja) * | 2005-07-06 | 2009-01-08 | セプラコア インコーポレーテッド | エスゾピクロン及びo−デスメチルベンラファキシンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法 |
EP2275095A3 (en) | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
US7476737B2 (en) * | 2005-09-05 | 2009-01-13 | Dr. Reddy's Laboratories Limited | Eszopiclone process |
EP2377530A3 (en) | 2005-10-21 | 2012-06-20 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
EP2314289A1 (en) | 2005-10-31 | 2011-04-27 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
EP1984371A1 (en) * | 2006-02-03 | 2008-10-29 | Synthon B.V. | Zopiclone resolution using l-tartaric acid |
US20100216734A1 (en) * | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
AU2007223036A1 (en) * | 2006-03-08 | 2007-09-13 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
US20080027223A1 (en) * | 2006-03-23 | 2008-01-31 | Teva Pharmaceutical Industries Ltd. | Polymorphs of eszopiclone malate |
JP2008543953A (ja) * | 2006-04-20 | 2008-12-04 | テバ ファーマシューティカル インダストリーズ リミティド | エスゾピクロン結晶形態a、実質的に純粋なエスゾピクロン及び光学的に豊富なエスゾピクロンを調製するための方法 |
CN101058581B (zh) * | 2006-04-21 | 2011-06-08 | 天津天士力集团有限公司 | 右佐匹克隆中间体6-(5-氯-2-吡啶基)-5,7-二氧代-6,7-二氢-5H-吡咯并[3,4-b]吡嗪的制备方法 |
WO2007134077A2 (en) * | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
CA2651813A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
US20100009983A1 (en) * | 2006-05-09 | 2010-01-14 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
US20080015197A1 (en) * | 2006-06-26 | 2008-01-17 | Alex Mainfeld | Process for the preparatrion of zopiclone |
AU2007292848A1 (en) * | 2006-09-08 | 2008-03-13 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
AU2007299920A1 (en) * | 2006-09-19 | 2008-03-27 | Braincells, Inc. | PPAR Mediated Modulation of Neurogenesis |
US7786304B2 (en) * | 2006-11-06 | 2010-08-31 | Centaur Pharmaceutical Pvt. Ltd. | Process for the preparation of eszopiclone |
WO2008094690A2 (en) * | 2007-01-31 | 2008-08-07 | Teva Pharmaceutical Industries Ltd. | Methods for preparing eszopiclone |
US20080305171A1 (en) * | 2007-06-07 | 2008-12-11 | Kristin Anne Arnold | Pyrrolopyrazine, formulations, methods of manufacture, and methods of use there |
WO2009002552A1 (en) * | 2007-06-25 | 2008-12-31 | Teva Pharmaceutical Industries Ltd. | Racemization process of r-zopiclone |
EP2020403A1 (en) | 2007-08-02 | 2009-02-04 | Esteve Quimica, S.A. | Process for the resolution of zopiclone and intermediate compounds |
US20090198058A1 (en) * | 2007-08-06 | 2009-08-06 | Dhananjay Govind Sathe | Process for Preparation of Dextrorotatory Isomer of 6-(5- chloro-pyrid-2-yl)-5-[(4-methyl -1-piperazinyl) carbonyloxy] -7-oxo-6,7-dihydro-5H-pyrrolo [3,4-b] pyrazine (Eszopiclone) |
JP2011506427A (ja) * | 2007-12-11 | 2011-03-03 | シプラ・リミテッド | ゾピクロンおよびその多形相の新規製造方法 |
WO2009085972A1 (en) * | 2007-12-19 | 2009-07-09 | Sepracor Inc. | Maleate, besylate, and l-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine |
US8268832B2 (en) * | 2007-12-19 | 2012-09-18 | Sunovion Pharmaceuticals Inc. | Maleate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
US8198277B2 (en) | 2007-12-19 | 2012-06-12 | Sunovion Pharmaceuticals Inc. | L-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
US8198278B2 (en) | 2007-12-19 | 2012-06-12 | Sunovion Pharmaceuticals Inc. | Besylate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
CN100467471C (zh) * | 2007-12-19 | 2009-03-11 | 齐鲁天和惠世制药有限公司 | 佐匹克隆的制备方法 |
US8212036B2 (en) | 2007-12-19 | 2012-07-03 | Sunovion Pharmaceuticals Inc. | Maleate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
US8269005B2 (en) * | 2007-12-19 | 2012-09-18 | Sunovion Pharmaceuticals Inc. | L-malate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-Oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
US20110053945A1 (en) * | 2007-12-19 | 2011-03-03 | Sepracor Inc. | Salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihy-dro-5h-pyrrolo[3,4-b]pyrazine |
EP3632417A1 (en) | 2009-01-30 | 2020-04-08 | Sunovion Pharmaceuticals Inc. | Coated tablets of 6-(5-chloro-2-pyridyl) -5-[ (4-methyl-1-piperazinyl) carbonyloxy]-7-oxo-6, 7-dihydro-5h-pyrrolo [3,4-b] pyrazine |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
CN105399745A (zh) * | 2015-12-17 | 2016-03-16 | 天津华津制药有限公司 | 一种吡嗪并羟基吡咯烷酮类化合物的制备方法 |
WO2017214442A1 (en) | 2016-06-08 | 2017-12-14 | President And Fellows Of Harvard College | Methods and compositions for reducing tactile dysfunction and anxiety associated with autism spectrum disorder, rett syndrome, and fragile x syndrome |
CN106220630B (zh) * | 2016-07-23 | 2019-12-10 | 迪嘉药业集团有限公司 | 一种n-取代吡咯并[3,4-b]吡嗪-5,7(6h)-二酮的制备方法 |
WO2019232046A1 (en) * | 2018-05-29 | 2019-12-05 | President And Fellows Of Harvard College | Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment |
WO2020198275A1 (en) | 2019-03-25 | 2020-10-01 | President And Fellows Of Harvard College | Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment |
-
1972
- 1972-12-14 OA OA54780A patent/OA04285A/xx unknown
- 1972-12-28 DD DD167951A patent/DD102698A5/xx unknown
- 1972-12-29 US US319876A patent/US3862149A/en not_active Expired - Lifetime
- 1972-12-29 NL NL7217852A patent/NL7217852A/xx unknown
-
1973
- 1973-01-04 HU HURO691A patent/HU164821B/hu unknown
- 1973-01-04 IL IL41232A patent/IL41232A/xx unknown
- 1973-01-04 IE IE12/73A patent/IE37056B1/xx unknown
- 1973-01-04 AU AU50754/73A patent/AU466586B2/en not_active Expired
- 1973-01-05 LU LU66800A patent/LU66800A1/xx unknown
- 1973-01-05 CY CY915A patent/CY915A/xx unknown
- 1973-01-05 JP JP48000069A patent/JPS523952B2/ja not_active Expired
- 1973-01-05 DK DK6973AA patent/DK139359B/da not_active IP Right Cessation
- 1973-01-05 NO NO62/73A patent/NO136843C/no unknown
- 1973-01-05 AR AR246000A patent/AR195097A1/es active
- 1973-01-05 DE DE2300491A patent/DE2300491C3/de not_active Expired
- 1973-01-05 GB GB79073A patent/GB1358680A/en not_active Expired
- 1973-01-05 BE BE793730D patent/BE793730A/xx active Protection Beyond IP Right Term
- 1973-01-05 AT AT10073A patent/AT323181B/de active
- 1973-01-05 FI FI27/73A patent/FI54124C/fi active
- 1973-01-05 SE SE7300159A patent/SE398503B/xx active Protection Beyond IP Right Term
- 1973-01-05 CA CA160,620A patent/CA991183A/fr not_active Expired
-
1976
- 1976-09-08 JP JP51106831A patent/JPS5248687A/ja active Granted
- 1976-09-08 JP JP51106832A patent/JPS5248688A/ja active Granted
-
1977
- 1977-12-01 HK HK600/77A patent/HK60077A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JPS5248687A (en) | 1977-04-18 |
IL41232A (en) | 1975-12-31 |
DE2300491B2 (de) | 1977-09-08 |
CA991183A (fr) | 1976-06-15 |
DE2300491C3 (de) | 1978-05-18 |
NL7217852A (sl) | 1973-07-10 |
JPS4876892A (sl) | 1973-10-16 |
IE37056L (en) | 1973-07-07 |
LU66800A1 (sl) | 1973-07-18 |
OA04285A (fr) | 1979-12-31 |
HK60077A (en) | 1977-12-09 |
DK139359C (sl) | 1979-07-09 |
IL41232A0 (en) | 1973-03-30 |
BE793730A (fr) | 1973-07-05 |
AU5075473A (en) | 1974-07-04 |
GB1358680A (en) | 1974-07-03 |
NO136843C (no) | 1977-11-16 |
NO136843B (no) | 1977-08-08 |
FI54124C (fi) | 1978-10-10 |
AR195097A1 (es) | 1973-09-10 |
JPS5248688A (en) | 1977-04-18 |
DK139359B (da) | 1979-02-05 |
AU466586B2 (en) | 1975-10-30 |
IE37056B1 (en) | 1977-04-27 |
SE398503B (sv) | 1977-12-27 |
DE2300491A1 (de) | 1973-07-19 |
US3862149A (en) | 1975-01-21 |
JPS535315B2 (sl) | 1978-02-25 |
JPS5231358B2 (sl) | 1977-08-13 |
JPS523952B2 (sl) | 1977-01-31 |
AT323181B (de) | 1975-06-25 |
HU164821B (sl) | 1974-04-11 |
FI54124B (fi) | 1978-06-30 |
DD102698A5 (sl) | 1973-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY915A (en) | Pyrrolo (3,4-b) pyrazine derivatives | |
CA989843A (en) | 2-alkyl-3-acyl-pyrazolo(1,5-a) pyridines | |
PH10625A (en) | 1,3,4,9-tetrahydropyrano-or 1,3,4,9-tetrahydrothiopyrano-(3,4-b)indole derivatives | |
CA999860A (en) | Imidazo-(1,2-a)-(benzodiazepine-1,4) compounds | |
HK4080A (en) | Imidazo(4,5-b)pyridines | |
ZA745673B (en) | S-triazol(1,5-a) pyridine derivative | |
CA1010032A (en) | Imidazo (3,4-d)-dibenzo-oxazepines, -thiazepines, and -diazepines | |
ZA727468B (en) | Pyrrolo(3,4-b)pyridine derivatives | |
ZA74734B (en) | Imidazo(1,2-a)azacycloalkanes | |
CA1013747A (fr) | Procede de preparation de derives du 9h-pyrido/3,4-b/indole | |
CA970373A (en) | Pyrazolo (3,4-b) pyridine-5-carboxamides | |
CY959A (en) | 1,4-dithino(2,3-c)pyrrole derivatives | |
ZA7372B (en) | Pyrrolo(3,4-b)pyrazine derivatives | |
AU465283B2 (en) | PYRIDO 4, 3-c PYRIDAZINE COMPOUNDS | |
PH11677A (en) | 6,7,8,9-tetrahydro-1h-pyrazolo(3,4-b)(1,5)diazocine derivatives | |
AU475861B2 (en) | 6-phenyl-4h-v-triazolo /1,5-a/1,4/ benzodiazepines | |
CA925510A (en) | (pyrazolo(3,4-b)pyridin-5-yl-formamidoethyl) phenylsulfonylureas | |
CA979901A (en) | 1,2-dihydro-2-oxopyrimido (4,5-b) quinoxaline derivatives | |
ZA726070B (en) | New process for the preparation of s.triazolo(4,3-a)pyridine derivatives | |
ZA716300B (en) | Imidazo(4,5-b)pyridine derivatives | |
CA893707A (en) | Pyrazine derivatives | |
IE35664B1 (en) | Imidazo (4,5-b) pyridine derivatives | |
AU420900B2 (en) | OXAZOLO(3, 2a) PYRROLO (2,1-a) PYRAZINE DERIVATIVES PREPARATION THEREOF | |
CA810220A (en) | 1h-pyrazolo(3,4-b) pyridines | |
CA884895A (en) | Thiazolo (3,2-a) pyrimidine derivatives |